Today on Medscape

Top Stories from Across Medicine

Top Medical News from Across Medscape

  • FDA Approves Lixisenatide (Adlyxin) for Type 2 DiabetesThe latest GLP-1 agonist for the treatment of type 2 diabetes to gain approval in the US is lixisenatide; it's already approved under the brand name Lyxumia in more than 60 countries.


Nurses Blogs

Additional Resources


  • Faster, Higher, Stronger: A History of Doping in Sports Athletes have been using performance-enhancing drugs since the ancient Olympics, but despite progress in drug testing and periodic scandals, one expert contends that we really don't want them to stop.
  • Medscape Vaccine Acceptance Report 2016 We asked you whether vaccine acceptance is on the rise in your own practices. More than 1500 of you shared your experience.

Advisory Board


Site Editorial Director

Medscape Editor-in-Chief

  • Eric J. Topol, MD Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.